The presence of 1 or 2 APOE4 alleles increases AD risk by 2–3-fold and 10–15-fold, respectively, due to increased amyloid and tau aggregation, dysregulated cholesterol metabolism, and impaired synaptic plasticity [39,40,41]. Here, MAPT is linked to Alzheimer disease.